Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 3/20 | 0.54 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.54 |
| ▸ | MEN1 | O00255 | 2/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.52 |
| ▸ | ESR1 | P03372 | 1/20 | 0.52 |
| ▸ | APP | P05067 | 2/20 | 0.48 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | PKM | P14618 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | TYR | P14679 | 2/20 | 0.44 |
| ▸ | CA12 | O43570 | 2/20 | 0.44 |
| ▸ | CA1 | P00915 | 2/20 | 0.44 |
| ▸ | CA2 | P00918 | 2/20 | 0.44 |
| ▸ | CA9 | Q16790 | 2/20 | 0.44 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | GMNN | O75496 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10784953 | 0.85 | CA1 (0.50) | LTA4HMEN1KMT2AGAACA12 | |
| SCHEMBL20243981 | 0.83 | PKM (0.72) | LTA4HESR2GAAPKMLMNA | |
| SCHEMBL1191086 | 0.82 | ESR2 (0.65) | LTA4HESR2MEN1KMT2AESR1 | |
| Mequinol SCHEMBL21009 | 0.77 | — | — | |
| 1,4-Dimethoxybenzene SCHEMBL8351066 | 0.77 | ESR2 (0.84) | LTA4HESR2MEN1KMT2AESR1 | |
| Mequinol SCHEMBL166535 | 0.77 | ESR2 (0.84) | LTA4HESR2MEN1KMT2AESR1 | |
| SCHEMBL433779 | 0.77 | CA1 (0.69) | LTA4HESR2MEN1KMT2AGAA | |
| Mequinol SCHEMBL1535640 | 0.77 | ESR2 (0.84) | LTA4HESR2MEN1KMT2AESR1 | |
| Hydroquinone SCHEMBL21010 | 0.75 | CYP3A4 (0.67) | LTA4HESR2MEN1KMT2AESR1 | |
| Hydroquinone SCHEMBL756935 | 0.75 | CYP3A4 (0.67) | LTA4HESR2MEN1KMT2AESR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4423068-A1 | RXFP1 AGONISTS | Bristol-Myers Squibb Company (US) | 2024-09-04 | — | — | EP | disclosed |
| WO-2023077070-A1 | RXFP1 AGONISTS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2023-05-04 | — | — | WO | disclosed |
| WO-2022077823-A1 | APPLICATION OF MILOXACIN IN PREPARATION OF DRUG FOR TREATING AND/OR PREVENTING DISEASE TAKING T-TYPE CALCIUM CHANNEL AS THERAPEUTIC TARGET | 苏州大学 | 2022-04-21 | — | — | WO | disclosed |
| CN-111655662-A | Compound, resin, composition, resist pattern forming method, circuit pattern forming method, and resin purifying method | 三菱瓦斯化学株式会社 | 2020-09-11 | — | — | CN | disclosed |
| US-20120052440-A1 | SALT AND PHOTORESIST COMPOSITION COMPRISING THE SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-03-01 | — | — | US | disclosed |
| US-20110318690-A1 | COMPOUND, RESIN AND PHOTORESIST COMPOSITION | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-12-29 | — | — | US | disclosed |
| US-20110236827-A1 | RESIN AND PHOTORESIST COMPOSITION CONTAINING THE SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-09-29 | — | — | US | disclosed |
| US-20110165513-A1 | PHOTORESIST COMPOSITION | SUMITOMO CHEMICAL COMPANY LTD (JP) | 2011-07-07 | — | — | US | disclosed |
| US-20110059400-A1 | PHOTORESIST COMPOSITION | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-03-10 | — | — | US | disclosed |
| US-20110046362-A1 | METHODS OF MAKING NUCLEOSIDE TETRAPHOSPHATE | MICRODOSE THERAPEUTX, INC. | 2011-02-24 | — | — | US | disclosed |
| EP-0746306-B1 | BENZOYLACETATE ESTERS AS NON-SENSITIZING CHELATING PHOTO-PROTECTANTS | PROCTER & GAMBLE (US) | 2001-11-07 | — | — | EP | disclosed |
| US-4961870-A | CLEANING, DEGREASING, SOLVENTS | ALLIED-SIGNAL INC. (US) | 1990-10-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120052440-A1 | SALT AND PHOTORESIST COMPOSITION COMPRISING THE SAME | C1S, C1R, CLIC1 | LTA4H 4198/4885ESR2 2342/4885MEN1 1232/4885 |
| US-20110059400-A1 | PHOTORESIST COMPOSITION | C1R, C1S, CCNT1 | LTA4H 357/4885ESR2 1167/4885MEN1 1989/4885 |
| US-20110046362-A1 | METHODS OF MAKING NUCLEOSIDE TETRAPHOSPHATE | P2RY1, P2RY6, NUDT1 | LTA4H 271/4885ESR2 4468/4885MEN1 3173/4885 |
| US-20110236827-A1 | RESIN AND PHOTORESIST COMPOSITION CONTAINING THE SAME | C1R, CBR1, RCOR1 | LTA4H 950/4885ESR2 382/4885MEN1 3660/4885 |
| US-20110318690-A1 | COMPOUND, RESIN AND PHOTORESIST COMPOSITION | RCOR1, C1R, C1S | LTA4H 2506/4885ESR2 684/4885MEN1 1642/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.